Trial Profile
A multicenter, open-label, randomized, parallel groups study to assess the long-term safety performance of fexofenadine compared to montelukast in subjects with asthma
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 29 Jan 2009
Price :
$35
*
At a glance
- Drugs Fexofenadine (Primary) ; Montelukast
- Indications Asthma
- Focus Adverse reactions
- Sponsors Aventis Pharmaceuticals
- 14 Sep 2006 New trial record.